Pancreatic Neuroendocrine Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-01-23
Clinical Trial Update: A Trial to Assess the Activity and Safety of Palbociclib in Patients With Well and Moderately Differentiated Metastatic Pancreatic Neuroendocrine Tumors (pNET) [Phase 2]
Phase 2 trial assessing palbociclib in well/moderately differentiated metastatic pancreatic neuroendocrine tumors has completed.